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stem cell line—H1 have a pearson correlation of 0.936.
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Human fetal foreskin ﬁbroblasts (HFF1) were reprogrammed by
nucleofection of oriP/EBNA1 (Epstein–Barr nuclear antigen-1)-based
episomal vectors which express the reprogramming factors OCT4,
SOX2, NANOG, LIN28, KLF4, and c-MYC and were treated with three. This is an open access article undersmall molecules PD0325901 (inhibitor of MEK), SB431245 (inhibitor
of TGFβ) and CHIR99021 (inhibitor of GSK3β) (Yu et al., 2011). The
epiHFF1-B1 expresses the pluripotency-associated transcription factors
OCT4, NANOG, SOX2 and cell surface markers SSEA-4, TRA-l-60, TRA-1-
81 (Fig. 1A). Furthermore, pluripotency was demonstrated in vitro by
embryoid body-based differentiation to cell types representative of
the three germ layers endoderm, ectoderm, and mesoderm (Fig. 1B)
and in vivo by teratoma formation in immunodeﬁcient mice (Fig. 1C).
DNA ﬁngerprinting conﬁrmed the origin of the iHFF1-B1 (Fig. 1D).
Chromosomal analysis revealed amale karyotypewhich contains an ad-
dition on chromosome 12 with unknown origin (Fig. 1E). The dendro-
gram revealed the transcriptome of iHFF1-B1 to be much closer to
that of human embryonic stem cell line (H1) (R2 = 0.9363) than to
that of the parental cell line-HFF1 (R2 = 0.6931) and its viral derived
iPSC line (vHFF1-iPS4) (R2 = 0.7857) (Fig. 1F). The HFF1-derived
V-iPSC line used for this comparison has been described in Wang and
Adjaye (2011). After 12 passages, the iPSC-line epiHFF1-B1 had
completely lost the episomal vectors as shown by PCR (Fig. 1G).
2. Materials and methods
2.1. Cell culture
The HFF1 (ATCC; SCRC-1041) were cultured in DMEM (Gibco/Life
Technologies) with 10% FBS (Gibco/Life Technologies) at 37 °C and 5%
CO2 in an incubator (INNOVA CO-170 Incubator, New Brunswick Scien-
tiﬁc) under humidiﬁed atmosphere. The induced pluripotent stem cell
(iPSC) line was cultured on Matrigel-coated plates with mitotic
inactivated mouse embryonic ﬁbroblast (MEF) cells and an uncondi-
tioned medium (UM) (Wolfrum et al., 2010).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterization of the iPSC line epiHUVEC A) Immunoﬂuorescence-based detection of human pluripotent speciﬁc proteins OCT4, SOX2, NANOG, and surface marker SSEA-4, TRA-1-
60, and TRA-1-81 in iPSC line. DAPI stained thenucleus (blue). Scale bar: 100 μmAlexa Flour 594 (red), Alexa Fluor 488 (green). B) All three germ layersmesoderm, ectoderm, andendoderm
were detected in vitro by formation of embryoid bodies. Immunochemistry was performed for mesoderm protein Smooth-Muscle-Actin (SMA), ectoderm protein β-Tubulin III (TUJ1), and
endodermproteinα-Fetoprotein (AFP). DAPI stained the nucleus (blue). Scale bar: 100 μm,Alexa Flour 594 (red), Alexa Fluor 488 (green). C) Teratoma formation of E-iPSCs. 1:mesoderm, 2:
ectoderm, 3: endoderm. D) DNA ﬁngerprinting PCR products. DNAwas ampliﬁed using PCR primer sets that ﬂank different genomic regions containing VNTRs (1: D10S1214, 2: D17S1290,
and 3: D21S2055). E) Presence of a female karyogram 46,XY,add(12)(p13)[9]. F) Dendrogram of HFF1, two HFF1-derived iPSC lines, one retroviral-derived (vHFF1_iPS_iPS4), as well as one
episomal-derived iPSC line (epiHFF1_iPS_B1) and hESC. F) Vector loss detection in iPSCs at passage12. Detection of 1) EBNA-1 andOriP; 2) LIN28 and SV40LT; 3)NANOGandOCT4 aswell as
4) human genome gene sequence of OCT4. 100 bp Marker was used. The vector pEP4EO2SET2K was used as positive controls, H2O and the original cell line HFF1 as negative controls.
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To generate vector-free iPSCs, three oriP/EBNA1 (Epstein–Barr nu-
clear antigen-1)-based episomal vectors published by Yu et al. (2011)
were used (Yu et al., 2011). These vectors express the reprogramming
factors OCT4, SOX2, NANOG, KLF4, LIN28, c-MYC, and SV40LT. A
nucleofection was done by using a cell-speciﬁc Amaxa Cell Line
Nucleofector Kit (Lonza) and one single electroporation was sufﬁcient.
1 × 106 of the cells of interest were used. The cells were centrifuged
and then diluted in 100 μl Nucleofection Solution which contained the
vectors DNA. The amount of plasmids used for one nucleofection was
3.0 μg of pEP4EO2SEN2K, 3.0 μg of pEP4EO2SET2K, and 2.0 μg of
pCEP4-M2L as described by Yu et al. (2011). The transfected cells
were seeded on a 6-well-plate containing the same medium the cells
were cultured before the nucleofection. One day after nucleofection,
the cells were treated with the following small molecules: A TGFβ-
inhibitor (SB431245, Sigma, in a concentration of 2 μM), aMEK inhibitor
(PD0325901, Sigma, in a concentration of 1 μM), and a GSK3β-inhibitor
(CHIR99021, Sigma, in a concentration of 3 μM). Three weeks later, col-
onies with ES-like morphology were picked and expanded further.
4. Polymerase chain reaction
PCR reactions were used to detect the presence or absence of the
plasmids. The PCR was carried out using a Thermocycler type PTC100
(MJ Research Inc) for 32 cycles and each cycle contained 94 °C for
15 s, 58 °C for 30 s, and 68 °C for 1 min. Primer sequences are as de-
scribed by Yu et al. (2011).
5. Embryoid body formation
hESCs or iPSCs were seeded on ultra-low attachment dishes
(Corning) and cultured in DMEM (Gibco/Life Technologies). Theembryoid body (EB) formation was carried out as described in Matz
and Adjaye (2015).
6. Immunoﬂuorescence-based detection of proteins
The cells were ﬁxed with 4% paraformaldehyde for 20min at RT and
washed two timeswith PBS. The immunoﬂuorescence-based staining of
proteinswas carried out as described inMatz andAdjaye (2015). Prima-
ry antibodies were used as follows: OCT4 (Santa Cruz, no. sc-5279),
NANOG (R&D, no. AF1997), SOX2 (Santa Cruz, no. sc-17,320). Antibod-
ies against SSEA4, TRA-1-60, and TRA-1-81 of the hESC characterization
kit (Merck Millipore, no. SCR004) were used. In addition, antibodies
were used against Smooth-Muscle-Actin (SMA) (Dako, no. M0851), α-
Fetoprotein (AFP) (Sigma, no. WH0000174M1), β-Tubulin III (TUJ1)
(Sigma, no. T8660). The secondary antibody was either conjugated to
the dye Alexa Fluor 488 (Invitrogen, no. A11055) for green ﬂuorescence
or to Alexa Fluor 594 (Invitrogen, no. A21468) for red ﬂuorescence. The
nuclei of the cells were counterstained with 4′,6-Diamidin-2-
phenylindol (DAPI, 200 ng/ml, Invitrogen, no. H3570). Theﬂuorophores
on the secondary antibodies were visualized using a Zeiss, LSM 510
Meta confocal microscope with a connected camera for microscopy
model AxioCam ICc3 and the software Axiovision 4.6.
7. Teratoma formation
The in vivo differentiation experiments (teratoma formation) were
performed by EPO Berlin GmbH (Germany, http://www.epo-berlin.
de). Approximately 2 × 106 cells of the cell linewere harvested by com-
bined type IV collagenase treatment and 0.05% Trypsin/EDTA-treatment
and washed. Cells were resuspended in 50 μl PBS, then mixed with
Matrigel (1:2) and immediately injected subcutaneously into NOD.
Cg-rkdcscid Il2rgtm1Wjl/SzJ mice, commonly known as NOD scid gamma
(NSG). Teratoma formationwas carefullymonitored andmice sacriﬁced
69P. Matz, J. Adjaye / Stem Cell Research 16 (2016) 67–6963 d after injection. The teratomas were collected and processed using
standard procedures for paraﬁn embedding, then hematoxylin and
eosin staining. Histological analysis was performed by a pathologist.
8. Karyotype analysis
Chromosomal analysis was performed after GTG-banding by Prof.
Dr. G. Thiel (Praxis für Humangenetik, Friedrichstr. 147, 10,117 Berlin,
Germany). Twenty metaphases were counted and 6 karyograms
analyzed.
9. DNA ﬁngerprinting analysis
Target regions of genomic DNAwere ampliﬁed by polymerase chain
reaction (PCR). The PCR was carried out for 35 cycles and each cycle
contained 96 °C for 1 min, 55 °C for 1 min, and 72 °C for 1 min. The fol-
lowing primer sequences (5′–3′) were used for DNA ﬁngerprinting:
D10S1214 forward ATTGCCCCAAAACTTTTTTG, reverse TTGAAGACCA
GTCTGGGAAG; D17S1290 forward GCAACAGAGCAAGACTGTC, reverse
GGAAACAGTTAAATGGCCAA; and D21S2055 forward AACAGAACCAAT
AGGCTATCTATC and reverse TACAGTAAATCACTTGGTAGGAGA.
10. RNA-based Microarray analysis
Total RNA was isolated for each sample. For global gene expression
analysis on an Illumina microarray platform, quality-checked totalRNA was used. 500 ng RNA for each sample was used as input for the
ampliﬁcation and biotin labeling reactions (Illumina TotalPrep RNA
Ampliﬁcation Kit, Ambion, Austin, TX, USA), which precede bead chip
hybridizations. The cRNA synthesis, BeadChip hybridization, and
scanning was performed by ATLAS Biolabs GmbH (http://www.
atlasbiolabs.com). The dendrogram compares the expression data and
the correlation values were calculated using the Gene Expression Mod-
ule of the software GenomeStudio (Illumina).
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